CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 2011 Bank of America Merrill Lynch Health Care Conference on Wednesday, May 11, 2011 at 8:40 a.m. PT (11:40 a.m. ET) at Encore at Wynn Las Vegas.
